Market Access

Panel: ‘Moving from market access to patient access’- Patients as the new stakeholder

Michael Seewald- VP & WorldWide Head, Real World Evidence, Novartis/ Pilar Pinilla-Dominguez-...

Upload Type: Audio Only

Prove the value of an oncology product in a rapidly changing landscape

Anke van Engen- Principle, QuintilesIMS; speaking on proving the value of oncology products in a...

Upload Type: Audio & Slides

HTA Panel

Pilar Pinilla-Dominguez- Technical adviser, NICE/ Amr Makady- Policy adviser, Zinl/ Professor...

Upload Type: Audio Only

Prove lasting value through real world evidence for optimum pricing

Michael Schroeter- Head Personalised Reimbursment Models, Global Pricing and Market Access, Roche;...

Upload Type: Audio & Slides

Convert Value Into Price: Why The Payers Role Is Crucial

Professor Bertram Haussler- Chairman, IGES Institut; speaking on why the role of the payer is...

Upload Type: Audio & Slides

Considerations regarding early HTA consultation to optimize access

Reg Waldeck- Vice President Access, Pricing and Health Economics, Celldex Therapeutics; speaking on...

Upload Type: Audio & Slides

Considerations regarding early HTA consultation to optimize access

Reg Waldeck- Vice President Access, Pricing and Health Economics; speaking on HTA consultation...

Upload Type: Audio & Slides

Explore how innovative financing schemes can help you overcome payer budget restrictions

Simone Wyss- Head Global Payer Solutions & Value Demonstration, Takeda; speaking on innovative...

Upload Type: Audio Only

Pressure on Prices - Dealing with a Shifting Landscape

David Pruce- Senior Principal, Evidera; speaking on the shifting lansdcape of pricing

Upload Type: Audio & Slides

The Pharma-Payer relationship: how will it evolve and how will you change your approach?

Martin Price- VP Health Economics, Market Access and Reimbursement; speaking on the importance of...

Upload Type: Audio & Slides

The Pharma-Payer relationship: how will it evolve and how will you change your approach?

Martin Price- VP Health Economics, Market Access and Reimbursement, Janssen; speaking on the...

Upload Type: Audio & Slides

Understand the benefits of putting market access at the heart of your company culture

Thomas Hasmann- VP, HightPoint Solutions; speaking on the optimal role of the market access function

Upload Type: Audio & Slides

Assessing the Value of Immuno-Oncology: Challenges & Opportunities

Patrick Hopkinson- Executive Director Worldwide Health Economics and Outcomes Research, Bristol-...

Upload Type: Audio & Slides

Ensure a best-in-class value dossier by harmonising clinical and commercial priorities

Stefan Holmstrom- Executive Director HEOR, Astellas; speaking on harmonising clinical and...

Upload Type: Audio & Slides

Increase your understanding of the burden of illness through text mining

Asif Khan, Associate Director, Global HEOR, Sanofi; speaking on increasing understanding of...

Upload Type: Audio & Slides

Real World Evidence: who cares? Investigating how EU payers actually base decisions on RWE

Gavin Outteridge, Vice President, Kinapse and Korina Papadopoulou, Manager, Kinapse; speaking the...

Upload Type: Audio & Slides